Christopher Sjöwall1, Thomas Mandl2, Lillemor Skattum3,4, Martin Olsson3, Aladdin J Mohammad5,6. 1. Division of Neuro & Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. 2. Department of Clinical Sciences Malmö, Rheumatology, Lund University, Skåne University Hospital, Malmö, Sweden. 3. Clinical Immunology and Transfusion Medicine, Office for Medical Services, Lund, Sweden. 4. Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden. 5. Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden. 6. Department of Medicine, University of Cambridge, Cambridge, UK.
Abstract
Objectives: The aim was to describe the clinical characteristics and epidemiology of hypocomplementaemic urticarial vasculitis (HUV; anti-C1q vasculitis) in two geographically defined areas of Sweden. Methods: In the health-care districts surrounding Skåne University Hospital (mean population 950 560) and Linköping University Hospital (mean population 428 503), all incident cases of HUV residing within the study areas at the onset of disease were identified during the years 2000-15. The diagnosis of HUV was confirmed by review of medical records. Only patients meeting the proposed diagnostic HUV criteria and/or the 2012 Chapel Hill consensus definitions in combination with an ever-positive anti-C1q antibody test were included. Results: Sixteen patients (14 females) were identified during the study period. The median (interquartile range) age at diagnosis was 51 (40.7-56.7) years. Median (interquartile range) time of follow-up from diagnosis to 31 December 2015, or death, was 94 (46.5-136.2) months. The most frequent manifestations at diagnosis were urticaria (100%), arthritis (88%), followed by biopsy-proven glomerulonephritis (19%), episcleritis/scleritis (19%) and recurrent abdominal pain (13%). The annual incidence rate per million inhabitants was estimated as 0.7 (95% CI: 0.4, 1.1). Sixty-three per cent suffered from pulmonary disease at the last follow-up. Two patients died during the follow-up period. One patient underwent lung transplantation, and two patients proceeded to end-stage renal disease. The point prevalence on 31 December 2015 was 9.5/million (95% CI: 4.5, 14.5). Conclusion: Hypocomplementaemic urticarial vasculitis constitutes a rare, but not always benign condition. Renal and lung manifestations were severe in some cases, highlighting the need for careful screening and monitoring of this potentially serious condition.
Objectives: The aim was to describe the clinical characteristics and epidemiology of hypocomplementaemic urticarial vasculitis (HUV; anti-C1qvasculitis) in two geographically defined areas of Sweden. Methods: In the health-care districts surrounding Skåne University Hospital (mean population 950 560) and Linköping University Hospital (mean population 428 503), all incident cases of HUV residing within the study areas at the onset of disease were identified during the years 2000-15. The diagnosis of HUV was confirmed by review of medical records. Only patients meeting the proposed diagnostic HUV criteria and/or the 2012 Chapel Hill consensus definitions in combination with an ever-positive anti-C1q antibody test were included. Results: Sixteen patients (14 females) were identified during the study period. The median (interquartile range) age at diagnosis was 51 (40.7-56.7) years. Median (interquartile range) time of follow-up from diagnosis to 31 December 2015, or death, was 94 (46.5-136.2) months. The most frequent manifestations at diagnosis were urticaria (100%), arthritis (88%), followed by biopsy-proven glomerulonephritis (19%), episcleritis/scleritis (19%) and recurrent abdominal pain (13%). The annual incidence rate per million inhabitants was estimated as 0.7 (95% CI: 0.4, 1.1). Sixty-three per cent suffered from pulmonary disease at the last follow-up. Two patients died during the follow-up period. One patient underwent lung transplantation, and two patients proceeded to end-stage renal disease. The point prevalence on 31 December 2015 was 9.5/million (95% CI: 4.5, 14.5). Conclusion:Hypocomplementaemic urticarial vasculitis constitutes a rare, but not always benign condition. Renal and lung manifestations were severe in some cases, highlighting the need for careful screening and monitoring of this potentially serious condition.
Authors: Shamez N Ladhani; Helen Campbell; Jay Lucidarme; Steve Gray; Sydel Parikh; Laura Willerton; Stephen A Clark; Aiswarya Lekshmi; Andrew Walker; Sima Patel; Xilian Bai; Mary Ramsay; Ray Borrow Journal: BMC Infect Dis Date: 2019-06-14 Impact factor: 3.090
Authors: Viktoria Puhl; Hanna Bonnekoh; Jörg Scheffel; Tomasz Hawro; Karsten Weller; Peter von den Driesch; Hans-Joachim Röwert-Huber; José Cardoso; Margarida Gonçalo; Marcus Maurer; Karoline Krause Journal: Clin Transl Allergy Date: 2021-04 Impact factor: 5.871
Authors: Pavel Kolkhir; Hanna Bonnekoh; Emek Kocatürk; Michihiro Hide; Martin Metz; Mario Sánchez-Borges; Karoline Krause; Marcus Maurer Journal: World Allergy Organ J Date: 2020-03-05 Impact factor: 4.084